The ABPI is seeking clarification from the Department of Health on the future of the Earlier Access Scheme.
10 May 2011 Posted in
Dr Richard Barker
The aim of the scheme, which sets it apart from other initiatives, is to provide access for high-need patients to clearly defined high-benefit medicines that are not yet formally licensed. We understand this is on hold during the ‘pause’, not rejected by ministers.